Treatment of rheumatoid arthritis with curcumin analog 3,5-bis(arylidene)-4-piperidone.

Future Med Chem

School of Pharmacy, the Key Laboratory of Prescription Effect & Clinical Evaluation of State Administration of Traditional Chinese Medicine of China, Binzhou Medical University, Yantai, Shandong, China.

Published: November 2023

Rheumatoid arthritis (RA) is an inflammatory disease. Curcumin can inhibit NF-κB and reduce the expression of inflammation-related genes. To evaluate the potential development of in the clinical treatment of inflammatory diseases such as RA. Using a skeleton fusion strategy to synthesize curcumin analogues for . This work evaluates anti-inflammatory activity by conducting anti-arthritis experiments (adjuvant-induced RA models) on rats. Western blot and ELISA were used to detect the expression of inflammatory-related proteins and cytokines. Molecular docking analysis confirmed the binding effect of with active sites. inhibits NF-κB has a protective effect on arthritis caused by RA.

Download full-text PDF

Source
http://dx.doi.org/10.4155/fmc-2023-0119DOI Listing

Publication Analysis

Top Keywords

rheumatoid arthritis
8
treatment rheumatoid
4
arthritis curcumin
4
curcumin analog
4
analog 35-bisarylidene-4-piperidone
4
35-bisarylidene-4-piperidone rheumatoid
4
arthritis inflammatory
4
inflammatory disease
4
disease curcumin
4
curcumin inhibit
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!